Morningside Venture Investments Limited 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-04 4:19 pm Sale |
2023-09-25 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 2,313,227 3.430% |
-2,305,619 (-49.92%) |
Filing |
| 2023-08-17 5:15 pm Sale |
2023-08-15 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 4,618,846 6.860% |
-4,000,000 (-46.41%) |
Filing |
| 2023-04-03 4:43 pm Sale |
2023-03-29 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 8,618,846 12.920% |
-683,296 (-7.35%) |
Filing |
| 2022-09-30 4:05 pm Sale |
2022-09-23 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 9,302,142 15.890% |
-1,376,666 (-12.89%) |
Filing |
| 2022-01-25 4:54 pm Purchase |
2022-01-11 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 10,678,808 18.900% |
10,678,808 (New Position) |
Filing |